In lung cancer a somatic mutation in the pleckstrin homology (PH) domain of AKT1 that results in glutamic acid to lysine substitution at residue 17 (E17K) was reported with overall frequency of 0.6–2% [7,11,12,23–25]. The gene discussed is PLEK; the disease is lung cancer.